FDA Approves Cannabis Study for Veterans with PTSD

Image

FDA Approves Cannabis Study for Veterans with PTSD

Cannabis News
December 10, 2024

After years of back and forth, the U.S. Food and Drug Administration (FDA) approved a clinical trial to determine whether cannabis helps veterans with post-traumatic stress disorder (PTSD). This critical multi-state study, dubbed MJP2, will include more than 300 participants. The researchers argue



Read More: FDA Approves Cannabis Study for Veterans with PTSD

Comments are closed, but trackbacks and pingbacks are open.